Sharekhan

July 23, 2021

This is to inform you that Glenmark Life Sciences Limited is coming out with a public issue to raise Rs.1,513.60 crore from the market.

The issue opens on July 27 and closes on July 29, 2021.

Details of the Glenmark Life Sciences Limited IPO

Company Details	:	Glenmark Life Sciences Limited is a leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (“APIs”) in chronic therapeutic areas, including cardiovascular disease (“CVS”), central nervous system disease (“CNS”), pain management and diabetes (Source: Frost & Sullivan Report). They also manufacture and sell APIs for gastro-intestinal disorders, anti-infectives and other therapeutic areas. They have strong market share in select specialized APIs such as Telmisartan (anti-hypertensive), Atovaquone (anti-parasitic), Perindopril (anti-hypertensive), Teneligliptin (diabetes), Zonisamide (CNS) and Adapalene (dermatology) (Source: Frost & Sullivan Report). They also increasingly providing contract development and manufacturing operations (“CDMO”) services to a range of multinational and specialty pharmaceutical companies. They are a wholly-owned subsidiary of their Promoter, Glenmark Pharmaceuticals Limited (“Glenmark”), a research-oriented, innovation led, global pharmaceutical company, which was established in 1977 and is listed on the BSE and NSE. As of March 31, 2021, They had a portfolio of 120 molecules globally and sold their APIs in India and exported their APIs to multiple countries in Europe, North America, Latin America, Japan and the rest of the world (“ROW”). As of May 31, 2021, they had filed 403 Drug Master Files (“DMFs”) and Certificates of suitability to the monographs of the European Pharmacopoeia (“CEPs”) across various major markets (i.e. United States, Europe, Japan, Russia, Brazil, South Korea, Taiwan, Canada, China and Australia). As of March 31, 2021, 16 of the 20 largest generic companies globally were their customers (Source: “A Year of Surprises Shakes Up Off-Patent Industry” \| Informa, 2020). They currently operate four multi-purpose manufacturing facilities which are situated on leasehold properties located at Ankleshwar and Dahej in the state of Gujarat, India, and Mohol and Kurkumbh in the state of Maharashtra, India with an aggregate annual total installed capacity of 726.6 KL as of March 31, 2021. Companies R&D laboratories focus on new product development and complex molecules, cost improvement programs, process improvements and oncology product development.
Issue Period	:	Issue opens on: Tuesday, July 27, 2021 Issue closes on: Thursday, July 29, 2021
Price Band	:	Rs.695 to Rs.720 per equity share
Bid Lot	:	20 shares and in multiples thereof
Issue Size	:	Rs.1,513.60 crore
Issue break-up	:	QIB - 50% of the offer – Rs.756.80 crore NIB - 15% of the offer - Rs.227.04 crore RET - 35% of the offer - Rs.529.76 crore
Listing	:	NSE and BSE
Registrar	:	KFin Technologies Private Limited .
UPI	:	All Retail Applications through brokers are compulsorily in UPI Mode

Watch these 4 videos to know how to apply for the Glenmark Life Sciences Limited IPO online easily.

Step 1: Create an UPI ID

Create UPI ID

Step 2: Apply for IPO online using mobile app or website

Step 3: Authorise UPI mandate to block payment

Authorised UPI ID

Remember these points while applying for IPOs

With Sharekhan, you can now fill and submit your IPO application online at your convenience anytime before an issue closes. This can be done through the Sharekhan app or website.
You will need a mobile phone with a SIM linked to your bank account offering the UPI facility and a debit card to create your UPI ID.

Currently, UPI works on the following mobile applications:

Name of App (Supported Platforms)	VPA Handle
BHIM Baroda Pay (only Android)	@BARODAMPAY
BHIM Oriental Pay (Only Android)	@obc
BHIM RBL Pay (Android & iOS)	@rbl
BHIM (android & iOS)	@upi
BHIM ALLBANK UPI (only Android)	@allbank
BHIM Axis Pay (only android)	@axisbank
BHIM IndusPay (only Android)	@indus
BHIM Lotza UPI (only Android)	@federal
BHIM SBIPay (only android)	@sbi
Citi Mobile (android & iOS)	@citi & @citigold
Google Pay (android & iOS)	@okhdfcbank \| @okaxis \| @oksbi \| @okicici
HSBC Simply Pay (android & iOS)	@hsbc
iMobile by ICICI Bank (android users)	@icici
Kotak Mobile Banking App (Android)	@kotak
Phone-Pe (android & iOS)	@ybl
SIB Mirror+ (only Android)	@sib
BHIM YES PAY (only Android)	@yesbank
DigiBank - DBS (Android & iOS	@dbs
Paytm (Andriod & iOS)	@paytm

To avoid rejection, download the latest version of the app.
Remember to select UPI as the payment option in the IPO application form by providing your UPI ID.
As soon as you submit your application through the mobile app or website, you will receive an SMS from National Payments Corporation of India (NPCI) informing you that your UPI mandate has been generated.
The app passcode and the UPI PIN can be different; remember to enter only the UPI PIN while authorising the UPI mandate. Note that you should not share your UPI PIN with anyone.
If you forget the UPI PIN, simply reset it instead of entering a wrong one.
If the transaction gets through, you will receive a “Transaction is successful” message on your mobile.
There are two possible scenarios post-allotment: On full allotment, funds will be debited from your account. If there is no allotment of shares, the blocked funds will be released after the end date or expiry date of the UPI mandate.

Published by Team Internal Communications
This newsletter is for internal circulation only. It may not be published, reproduced or quoted in part or in whole, nor may it be published on social media without prior consent. The content is strictly copyright and reproduction of the whole or part of it in any form is prohibited without written permission from the Internal Communications department of Sharekhan.

Join us on